RT Journal Article
SR Electronic
T1 TACE Combined with PSE in Treating Hepatocelluar Carcinoma with Hypersplenism
JF Chinese Journal of Clinical Oncology
JO Cancer Biol Med
FD China Anti-Cancer Association
SP 627
OP 630
VO 2
IS 3
A1 Xiuying Guo
A1 Zhi Guo
A1 Haipeng Yu
A1 Fang Liu
A1 Junyi Zhang
A1 Jizhong Xing
YR 2005
UL http://www.cancerbiomed.org/content/2/3/627.abstract
AB OBJECTIVE To observe the effectiveness and safety of transcatheter arterial chemoembolization (TACE) combined with partial splenic embolization (PSE) in treating primary hepatocelluar carcinoma (HCC) with hypersplenism.METHODS Thirty HCC patients with liver cirrhosis, portal hypertension and hypersplenism were treated with TACE and PSE. The degree of tumor volume reduction and remission of hypersplenism were observed.RESULTS The tumor reduction rate of the HCC was 73.3%. Twenty-eight patients had hypersplenic remission with a rate of 93.3%. There were no severe complications such as hepatic abscesses.CONCLUSION TACE combined with PSE is a safe and effective method to treat HCC with liver cirrhosis, portal hypertension and hypersplenism.